 Applied Therapeutics Inc NASDAQ: APLT has reported initial biomarker data from the pediatric ACTION-Galactosemia Kids study and baseline analysis of the 47 children enrolled in the study. Related Content: FDA Fast Track Review For AT-007 In Rare Metabolic Disorder. 